{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:10:11Z","timestamp":1790845811053,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:00:00Z","timestamp":1549324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jsps.2019.02.001","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T18:56:31Z","timestamp":1549392991000},"page":"540-549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Novel sublingual tablets of Atorvastatin calcium\/Trimetazidine hydrochloride combination; HPTLC quantification, in vitro formulation and characterization"],"prefix":"10.1007","volume":"27","author":[{"given":"Noha N.","family":"Atia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9789-9953","authenticated-orcid":false,"given":"Hesham M.","family":"Tawfeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza H.","family":"Rageh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa R.","family":"El-Zahry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Abdelfattah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A.","family":"Younis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"6","key":"10.1016\/j.jsps.2019.02.001_b0005","first-page":"195","article-title":"Design and evaluation of domperidone sublingual tablets","volume":"8","author":"Aboutaleb","year":"2016","journal-title":"Int. J. Pharm. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.jsps.2019.02.001_b0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7324\/JAPS.2016.60720","article-title":"Improvement of domperidone solubility and dissolution rate by dispersion in various hydrophilic carriers","volume":"6","author":"Aboutaleb","year":"2016","journal-title":"J. App. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.jsps.2019.02.001_b0015","first-page":"290","article-title":"Enhancement of solubility and dissolution rate of different forms of atorvastatin calcium in direct compression tablet formulas","volume":"57","author":"Ahjel","year":"2009","journal-title":"Farmacia"},{"issue":"2","key":"10.1016\/j.jsps.2019.02.001_b0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2174\/1573411013666170919162026","article-title":"High sensitivity determination of atorvastatin calcium in pharmaceuticals and biological fluids using adsorptive anodic stripping voltammetry onto surface of ultra-trace graphite electrode","volume":"14","author":"Al-ghamdi","year":"2018","journal-title":"Curr. Anal. Chem."},{"issue":"2","key":"10.1016\/j.jsps.2019.02.001_b0030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jsps.2011.09.005","article-title":"Validated capillary electrophoresis method for simultaneous determination of ezetimibe and atorvastatin in pharmaceutical formulations","volume":"20","author":"AlShehri","year":"2012","journal-title":"Saudi Pharm. J."},{"issue":"5","key":"10.1016\/j.jsps.2019.02.001_b0035","first-page":"629","article-title":"Spectrophotometric method for the determination of trimetazidine dihydrochloride from pharmaceutical forms","volume":"58","author":"Aurelia Chi\u015f","year":"2010","journal-title":"Farmacia"},{"issue":"6","key":"10.1016\/j.jsps.2019.02.001_b0040","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1248\/cpb.c15-00023","article-title":"Application of new spectrofluorometric techniques for determination of atorvastatin and ezetimibe in combined tablet dosage form","volume":"63","author":"Ayad","year":"2015","journal-title":"Chem. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.jsps.2019.02.001_b0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jare.2012.01.003","article-title":"Spectrophotometric and TLC-densitometric methods for the simultaneous determination of ezetimibe and atorvastatin calcium","volume":"4","author":"Baghdady","year":"2013","journal-title":"J. Adv. Res."},{"issue":"4","key":"10.1016\/j.jsps.2019.02.001_b0050","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/jaoac\/87.4.827","article-title":"Determination of trimetazidine dihydrochloride in the presence of its acid-induced degradation products","volume":"87","author":"Bebawy","year":"2004","journal-title":"J. AOAC Int."},{"issue":"2","key":"10.1016\/j.jsps.2019.02.001_b0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3329\/dujps.v10i2.11783","article-title":"Validation and optimization of a simple RP-HPLC method for determination of trimetazidine in human serum and its application in a pharmacokinetic study with healthy bangladeshi male volunteers","volume":"10","author":"Chowdhury","year":"2018","journal-title":"Dhaka University J. Pharm. Sci."},{"key":"10.1016\/j.jsps.2019.02.001_b0060","unstructured":"Council of Europe, editor. European Pharmacopoeia. 8th ed. Strasbourg: European Directorate for the Quality of Medicines and Health Care; 2014."},{"issue":"1\u20133","key":"10.1016\/j.jsps.2019.02.001_b0065","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejphar.2009.02.009","article-title":"PM101: A cyclodextrin-based intravenous formulation of amiodarone devoid of adverse hemodynamic effects","volume":"607","author":"Cushing","year":"2009","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.jsps.2019.02.001_b0070","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.saa.2011.08.005","article-title":"Three different spectrophotometric methods manipulating ratio spectra for determination of binary mixture of amlodipine and atorvastatin","volume":"83","author":"Darwish","year":"2011","journal-title":"Spectrochim. Acta Part A"},{"issue":"2","key":"10.1016\/j.jsps.2019.02.001_b0075","first-page":"68","article-title":"Validation of spectrophotometric dissolution method for modified release trimetazidine pharmaceutical dosage form","volume":"4","author":"Farzana","year":"2017","journal-title":"J. Innov. Pharm. Biolog. Sci."},{"issue":"1\u20132","key":"10.1016\/j.jsps.2019.02.001_b0085","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0731-7085(01)00525-8","article-title":"Determination of trimetazidine HCl by adsorptive stripping square-wave voltammetry at a glassy carbon electrode","volume":"27","author":"Ghoneim","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.jsps.2019.02.001_b0090","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/chromsci\/bms131","article-title":"Development and validation of stability-indicating assay method by UPLC for a fixed dose combination of atorvastatin and ezetimibe","volume":"51","author":"Goell","year":"2013","journal-title":"J. Chromatogr. Sci."},{"issue":"12","key":"10.1016\/j.jsps.2019.02.001_b0095","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/elps.200500899","article-title":"Rapid analysis of atorvastatin calcium using capillary electrophoresis and microchip electrophoresis","volume":"27","author":"Guihen","year":"2006","journal-title":"Electrophoresis"},{"issue":"9","key":"10.1016\/j.jsps.2019.02.001_b0105","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1211\/jpp.58.9.0004","article-title":"Preparation and evaluation of self-micro emulsifying drug delivery systems (SMEDDS) containing atorvastatin","volume":"58","author":"Hai","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"issue":"23","key":"10.1016\/j.jsps.2019.02.001_b0110","first-page":"4642","article-title":"Effects of atorvastatin combined with trimetazidine on myocardial injury and inflammatory mediator in unstable angina patients during perioperative of percutaneous coronary intervention","volume":"19","author":"Hao","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol Sci."},{"issue":"3","key":"10.1016\/j.jsps.2019.02.001_b0115","doi-asserted-by":"crossref","first-page":"791","DOI":"10.5740\/jaoacint.11-204","article-title":"Simultaneous determination of atorvastatin calcium and olmesartan medoxomil in a pharmaceutical formulation by reversed phase high-performance liquid chromatography, high-performance thin-layer chromatography and UV spectrophotometric methods","volume":"97","author":"Hiral","year":"2014","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.jsps.2019.02.001_b0120","unstructured":"International Conference on Harmonization, Topic Q2 (R1) Validation of Analytical Procedures: Text and Methodology, n.d. http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Quality\/Q2_R1\/Step4\/Q2_R1__Guideline.pdf."},{"key":"10.1016\/j.jsps.2019.02.001_b0125","first-page":"68","article-title":"The clinical short-term outcome of atorvastatin and trimetazidine combination treatment in patients with non-ST segment elevation acute coronary syndromes undergoing percutaneous coronary intervention","volume":"8","author":"Jiangyou","year":"2016","journal-title":"Int. Cardiovasc. Forum J."},{"issue":"4","key":"10.1016\/j.jsps.2019.02.001_b0130","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1208\/s12249-011-9673-3","article-title":"Enhanced bioavailability of atorvastatin calcium from stabilized gastric resident formulation","volume":"12","author":"Khan","year":"2011","journal-title":"AAPS Pharm. Sci. Tech."},{"issue":"12","key":"10.1016\/j.jsps.2019.02.001_b0135","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1021\/js980109t","article-title":"Inclusion complexation of ziprasidone mesylate with beta-cyclodextrin sulfobutyl ether","volume":"87","author":"Kim","year":"1998","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.jsps.2019.02.001_b0140","first-page":"6","article-title":"Application of assumed IVIVC in product life cycle management: a case study of trimetazidine dihydrochloride extended release tablet","volume":"5","author":"Kumar","year":"2013","journal-title":"J. Bioequiv. Biovailab."},{"issue":"1","key":"10.1016\/j.jsps.2019.02.001_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4068\/cmj.2013.49.1.1","article-title":"Role of statins in coronary artery disease","volume":"49","author":"Lim","year":"2013","journal-title":"Chonnam. Med. J."},{"issue":"2","key":"10.1016\/j.jsps.2019.02.001_b0150","doi-asserted-by":"crossref","first-page":"545","DOI":"10.12669\/pjms.292.2937","article-title":"Cardioprotective effects of atorvastatin plus trimetazidine in percutaneous coronary intervention","volume":"29","author":"Lin","year":"2013","journal-title":"Pak. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.jsps.2019.02.001_b0155","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/2229-4708.103892","article-title":"Validated spectrophotometric methods for the simultaneous determination of telmisartan and atorvastatin in bulk and tablets","volume":"3","author":"Llango","year":"2012","journal-title":"Pharm. Methods"},{"issue":"10","key":"10.1016\/j.jsps.2019.02.001_b0165","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/jps.20160","article-title":"In vitro and in vivo evaluation of a sulfobutyl ether \u03b2-cyclodextrin enabled etomidate formulation","volume":"93","author":"McIntosh","year":"2004","journal-title":"J. Pharm Sci."},{"issue":"3","key":"10.1016\/j.jsps.2019.02.001_b0175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4103\/0975-1483.100021","article-title":"Effect of a disintegration mechanism on wetting, water absorption, and disintegration time of orodispersible tablets","volume":"4","author":"Pabari","year":"2012","journal-title":"J Young Pharm."},{"issue":"3","key":"10.1016\/j.jsps.2019.02.001_b0180","first-page":"217","article-title":"Solubility and stability enhancement of atorvastatin by cyclodextrin complexation","volume":"63","author":"Palem","year":"2009","journal-title":"PDA. J. Pharm. Sci. Technol."},{"issue":"1","key":"10.1016\/j.jsps.2019.02.001_b0185","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/0975-1483.76420","article-title":"A validated densitometric method for analysis of atorvastatin calcium and metoprolol tartarate as bulk drugs and in combined capsule dosage forms","volume":"3","author":"Patole","year":"2011","journal-title":"J. Young Pharm."},{"issue":"9","key":"10.1016\/j.jsps.2019.02.001_b0190","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s40265-014-0233-5","article-title":"Defining the role of trimetazidine in the treatment of cardiovascular disorders: some insights on its role in heart failure and peripheral artery disease","volume":"74","author":"Piotr","year":"2014","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.jsps.2019.02.001_b0195","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1573411013666170525162241","article-title":"Utility of ionic liquid-based surfactant in enhancement of oxidation peak signal of atorvastatin at pencil graphite electrode","volume":"14","author":"Rageh","year":"2018","journal-title":"Curr. Anal. Chem."},{"issue":"3","key":"10.1016\/j.jsps.2019.02.001_b0200","first-page":"180","article-title":"TLC simultaneous determination of amlodipine, atorvastatin, rosuvastatin and valsartan in pure form and in tablets using phenyl-modified aleppo bentonite","volume":"6","author":"Ramadan","year":"2014","journal-title":"Int. J. Pharm. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.jsps.2019.02.001_b0215","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.powtec.2012.12.038","article-title":"Soluplus\u00ae: A novel polymeric solubilizer for optimization of Carvedilol solid dispersions: Formulation design and effect of method of preparation","volume":"237","author":"Shamma","year":"2013","journal-title":"Powder Technol."},{"issue":"3","key":"10.1016\/j.jsps.2019.02.001_b0220","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jpha.2012.01.005","article-title":"Validated spectrofluorimetric method for the determination of atorvastatin in pharmaceutical preparations","volume":"2","author":"Sharaf El-Din","year":"2012","journal-title":"J. Pharm. Anal."},{"issue":"3","key":"10.1016\/j.jsps.2019.02.001_b0225","first-page":"1281","article-title":"Formulation and evaluation of fast dissolving tablets containing taste masked microspheres of diclofenac sodium for sustained release","volume":"8","author":"Shazly","year":"2013","journal-title":"Digest J. Nano. Bio."},{"issue":"11","key":"10.1016\/j.jsps.2019.02.001_b0235","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s12272-011-1115-y","article-title":"Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants","volume":"34","author":"Sheshala","year":"2011","journal-title":"Arch. Pharmacal. Res."},{"issue":"5","key":"10.1016\/j.jsps.2019.02.001_b0245","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4066\/biomedicalresearch.29-17-3469","article-title":"Clinical effect of atorvastatin-trimetazidine combined treatment of coronary heart disease","volume":"29","author":"Song","year":"2018","journal-title":"Biomed. Res."},{"issue":"4","key":"10.1016\/j.jsps.2019.02.001_b0250","first-page":"1590","article-title":"The effects of crospovidone and croscarmellose sodium as superdisintegrants on the characteristics of piroxicam nanoparticles ODT (orally disintegrating tablet)","volume":"5","author":"Tanuwijaya","year":"2013","journal-title":"Int. J. Pharm. Tech. Res."},{"issue":"4","key":"10.1016\/j.jsps.2019.02.001_b0255","first-page":"1661","article-title":"Development and optimization of itopride hydrochloride fast disintegrating tablets using factorial design and response surface methodology","volume":"6","author":"Tawfeek","year":"2015","journal-title":"Int. J. Pharm. Sci. Res."},{"issue":"1","key":"10.1016\/j.jsps.2019.02.001_b0260","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijpharm.2017.08.069","article-title":"Colonic delivery of indometacin loaded PGA-co-PDL microparticles coated Eudragit L100 from fast disintegrating tablets","volume":"531","author":"Tawfeek","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.jsps.2019.02.001_b0265","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/10837450.2017.1329318","article-title":"Enalapril maleate orally disintegrating tablets: tableting and in vivo evaluation in hypertensive rats","volume":"23","author":"Tawfeek","year":"2018","journal-title":"Pharm. Dev. Tech."},{"issue":"14","key":"10.1016\/j.jsps.2019.02.001_b0270","first-page":"19","article-title":"Effects of atorvastatin combined with trimetazidine on cardiac function, inflammatory factors and endothelial function in patients with coronary artery disease","volume":"22","author":"Tian","year":"2016","journal-title":"J. Hainan Med. University"},{"issue":"4","key":"10.1016\/j.jsps.2019.02.001_b0275","first-page":"563","article-title":"Solubility enhancement of poorly water soluble drug atorvastatin calcium by solid dispersion technique using natural carrier","volume":"5","author":"Wadher","year":"2014","journal-title":"Pharmacophore"},{"issue":"2","key":"10.1016\/j.jsps.2019.02.001_b0280","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/cp.cp_11_18","article-title":"Effect of atorvastatin and trimetazidine combination treatment in patients with NSTE-ACS undergoing PCI","volume":"3","author":"Wang","year":"2018","journal-title":"Cardiology Plus"},{"issue":"1","key":"10.1016\/j.jsps.2019.02.001_b0285","doi-asserted-by":"crossref","first-page":"D 668","DOI":"10.1093\/nar\/gkj067","article-title":"Drug Bank: A comprehensive resource for in silico drug discovery and exploration","volume":"34","author":"Wishart","year":"2006","journal-title":"Nucl. Acids Res."},{"issue":"16","key":"10.1016\/j.jsps.2019.02.001_b0290","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1080\/10826076.2011.576298","article-title":"Validation of a rapid and simple LC-MS\/MS method to determine trimetazidine in rat plasma","volume":"34","author":"Xiong","year":"2011","journal-title":"J. Liq. Chrom. Rel. Technol."},{"issue":"8","key":"10.1016\/j.jsps.2019.02.001_b0295","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.4314\/tjpr.v16i8.35","article-title":"Atorvastatin\/trimetazidine combination therapy in patients with chronic cardiac failure","volume":"16","author":"Xu","year":"2017","journal-title":"Trop. J. Pharm. Res."},{"key":"10.1016\/j.jsps.2019.02.001_b0300","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1476-7120-5-51","article-title":"The effects of atorvastatin therapy on endothelial function in patients with coronary artery disease","volume":"5","author":"Yildiz","year":"2007","journal-title":"Cardiovas. Ultrasound"}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016418303396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016418303396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:32:39Z","timestamp":1736184759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016418303396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1319016418303396"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2019.02.001","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel sublingual tablets of Atorvastatin calcium\/Trimetazidine hydrochloride combination; HPTLC quantification, in vitro formulation and characterization","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2019.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}